Literature DB >> 11936878

Characterization of first trimester human fetal placental vessels using immunocytochemical markers.

J C Challier1, L Carbillon, A Kacemi, C Vervelle, T Bintein, M Galtier, M J Espié, S Uzan.   

Abstract

Cell differentiation markers on placental villi from the first trimester of human pregnancy have been studied by indirect immunofluorescence. Fluorescence labelling with antibodies against CD34 and CD31 was conspicuous in the vascular cells. The vascular paracellular clefts were labelled by anti-cadherin-5. A few vascular cells exhibited a positive reaction for von Willebrand factor, high-molecular-weight melanoma-associated-antibody and alpha-sm-actin compared to term pregnancy, indicating changes in protein expression during vascular differentiation. The poor anti-collagen IV reaction and the absence of a sm-myosin fluorescent signal observed around the vessels confirned the immaturity of the vessels. In contrast, strong reactions have previously been obtained with the latter antibodies in similar locations using term placental villi. A labelling was observed for antibodies against alpha3 and alpha5 integrins in these immature placental vessels suggesting cell-matrix interactions with specific domains of laminin or fibronectin. The vascular cells were also stained by anti-CD26. Surprisingly, the fetal vascular cells exhibited immunostainings in common with the villous cytotrophoblast (CD26) or the syncytiotrophoblast (cadherin-5) and cell islands cytotrophoblast (CD31, cadherin-5, alpha3 and alpha5 integrin subunits). These observations suggested a two step process for fetal vasculogenesis in the villi: i/ the formation of peripheral vessels induced by growth factors or cytokines derived from the nearby trophoblast, ii/ the development of muscular vessels due to growth factors or cytokines production induced by circulatory changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11936878

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  5 in total

1.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

2.  Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1.

Authors:  Ming-Yi Lee; Jian-Pei Huang; Yi-Yung Chen; John D Aplin; Yi-Hsin Wu; Chia-Yu Chen; Pei-Chun Chen; Chie-Pein Chen
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

3.  A new role for the human placenta as a hematopoietic site throughout gestation.

Authors:  Alicia Bárcena; Marcus O Muench; Mirhan Kapidzic; Susan J Fisher
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

4.  Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance.

Authors:  Manuel Wiesinger; Johannes März; Mirko Kummer; Gerold Schuler; Jan Dörrie; Beatrice Schuler-Thurner; Niels Schaft
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.639

5.  Angiogenin expression during early human placental development; association with blood vessel formation.

Authors:  Nadine Pavlov; Jean-Louis Frendo; Jean Guibourdenche; Séverine A Degrelle; Danièle Evain-Brion; Josette Badet
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.